Source: International Congress 2015 – COPD: interesting notes
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Anantharaj Suresh (Chennai, India), Anantharaj Suresh, Sindhuja Giritharan. CAT’ or ’mMRC’ – Which is a better symptom scale in recent GOLD COPD classification?. Eur Respir J 2015; 46: Suppl. 59, 398

Member's Comments

No comment yet.

Related content which might interest you: The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD Source: International Congress 2014 – COPD exacerbations Year: 2014 Comparison of CAT and mMRC in evaluating clinical symptoms co-morbidity and medical resource utilization in COPD patients Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 BODCAT index: Could we use it instead of BODE or BODEx to classify COPD severity? Source: International Congress 2014 – Clinical presentations Year: 2014 Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Comparison of CAT and CCQ in a clinical COPD population Source: International Congress 2014 – Clinical presentations Year: 2014 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Heterogeneity of group D in the new GOLD classification of COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Correlation between COPD assessment test (CAT) and mMRC dyspnea scale in evaluationg COPD symptoms Source: International Congress 2019 – Epidemiology of airway diseases in primary care Year: 2019 Symptomatic assessment in COPD GOLD 2011 classification - mMRC/CAT agreement Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016 COPD comorbidities and risk assessment according to GOLD 2011 revision Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Are the mMRC dyspnea scale of 2 and a CAT score of 10 equivalent as proposed by the GOLD strategy? Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 Significance of quantitative radiological phenotypes of COPD on BODE index Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Does the 2011 GOLD staging of COPD reflect phenotype and severity of the disease as assessed by CT? Source: Annual Congress 2013 –COPD treatment and others Year: 2013 COPD staging systems and BODE index Source: International Congress 2016 – Non-inflammatory assessment of airway disorders Year: 2016 GOLD BCD or 234 classifications: Which one better reflects COPD patients' functionality? Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014 The influence of bronchial asthma as a comorbidity of COPD on the COPD assessment test (CAT) Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Comparison of CAT and mMRC in terms of assessing symptom status in stable COPD patients Source: International Congress 2018 – Patient-reported outcomes and scores in COPD Year: 2018 Impact of comorbidities in COPD prognosys scores Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 New GOLD recommendations in a seven years follow up - changes in symptoms and risk categories Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013 Severity of airflow obstruction and multicomponent disease staging of COPD in the real-world primary care in Greece: The AEOLUS study Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016